Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 13;11(6):1701.
doi: 10.3390/biomedicines11061701.

Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis

Affiliations
Review

Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis

Cinzia Garofalo et al. Biomedicines. .

Abstract

Fibromyalgia (FM) is a serious chronic pain syndrome, characterised by muscle and joint stiffness, insomnia, fatigue, mood disorders, cognitive dysfunction, anxiety, depression and intestinal irritability. Irritable Bowel Syndrome (IBS) shares many of these symptoms, and FM and IBS frequently co-exist, which suggests a common aetiology for the two diseases. The exact physiopathological mechanisms underlying both FM and IBS onset are unknown. Researchers have investigated many possible causes, including alterations in gut microbiota, which contain billions of microorganisms in the human digestive tract. The gut-brain axis has been proven to be the link between the gut microbiota and the central nervous system, which can then control the gut microbiota composition. In this review, we will discuss the similarities between FM and IBS. Particularly, we will focus our attention on symptomatology overlap between FM and IBS as well as the similarities in microbiota composition between FM and IBS patients. We will also briefly discuss the potential therapeutic approaches based on microbiota manipulations that are successfully used in IBS and could be employed also in FM patients to relieve pain, ameliorate the rehabilitation outcome, psychological distress and intestinal symptoms.

Keywords: IBS; fibromyalgia; microbiota gut-brain axis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Trouvin A.P., Perrot S. New Concepts of Pain. Best Pract. Res. Clin. Rheumatol. 2019;33:101415. doi: 10.1016/j.berh.2019.04.007. - DOI - PubMed
    1. Siracusa R., Di Paola R., Cuzzocrea S., Impellizzeri D. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int. J. Mol. Sci. 2021;22:3891. doi: 10.3390/ijms22083891. - DOI - PMC - PubMed
    1. Yunus M.B. Fibromyalgia and Overlapping Disorders: The Unifying Concept of Central Sensitivity Syndromes. Semin. Arthritis Rheum. 2007;36:339–356. doi: 10.1016/j.semarthrit.2006.12.009. - DOI - PubMed
    1. Slim M., Calandre E.P., Rico-Villademoros F. An Insight into the Gastrointestinal Component of Fibromyalgia: Clinical Manifestations and Potential Underlying Mechanisms. Rheumatol. Int. 2015;35:433–444. doi: 10.1007/s00296-014-3109-9. - DOI - PubMed
    1. Raffaeli W., Malafoglia V., Bonci A., Tenti M., Ilari S., Gremigni P., Iannuccelli C., Gioia C., Di Franco M., Mollace V., et al. Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases. Int. J. Mol. Sci. 2020;21:1499. doi: 10.3390/ijms21041499. - DOI - PMC - PubMed

LinkOut - more resources